| Literature DB >> 28285700 |
Georgiana Bentea1, Claudine Sculier1, Bogdan Grigoriu1, Anne-Pascale Meert2, Valérie Durieux3, Thierry Berghmans2, Jean-Paul Sculier4.
Abstract
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the third of a series of five and deals mainly with neurological paraneoplastic syndromes involving the central nervous system.Entities:
Mesh:
Year: 2017 PMID: 28285700 DOI: 10.1016/j.lungcan.2017.01.017
Source DB: PubMed Journal: Lung Cancer ISSN: 0169-5002 Impact factor: 5.705